Registration Dossier

Diss Factsheets

Administrative data

Key value for chemical safety assessment

Genetic toxicity in vitro

Description of key information

No data exists for the target substance (liraglutide precursor). The conducted in vitro mutagenicity testing on MI3 (S3), X14DesB30 (S4) and Liraglutide (S1) do not indicate any mutagenic or clastogenic potential of the substances. Due to very close structural similarity to Liraglutide precursor a lack of mutagenic and clastogenic potential in vitro can be concluded for this substance as well.

See read-across template and justification attached in section 13

Endpoint conclusion
Endpoint conclusion:
no adverse effect observed (negative)

Genetic toxicity in vivo

Description of key information

No data exists for the target substance (liraglutide precursor).

The conducted in vivo study on Liraglutide (S1) does not indicate any genotoxic/clastogenic potential of the substance. Due to very close structural similarity to Liraglutide precursor a lack of genotoxic/ clastogenic potential in vivo can be concluded for this substance as well.

See read-across template and justification attached in section 13

Endpoint conclusion
Endpoint conclusion:
no adverse effect observed (negative)

Additional information

Justification for classification or non-classification

Overall, the conducted in vitro mutagenicity testing on MI3 and X14DesB30 and thein vitro studies and the in vivo study on liraglutide do not indicate any mutagenic or clastogenic potential of the substances. Due to the close structural similarity and similar physicochemical properties a lack of mutagenic and clastogenic potential can be concluded for liraglutide precursor as well.

Thus, no classification for mutagenicity according to the CLP-criteria applies.